These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8149967)
1. A fungal metabolite which inhibits the interaction of CD4 with major histocompatibility complex-encoded class II molecules. Gammon G; Chandler G; Depledge P; Elcock C; Wrigley S; Moore J; Cammarota G; Sinigaglia F; Moore M Eur J Immunol; 1994 Apr; 24(4):991-8. PubMed ID: 8149967 [TBL] [Abstract][Full Text] [Related]
2. Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120. Merkenschlager M; Buck D; Beverley PC; Sattentau QJ J Immunol; 1990 Nov; 145(9):2839-45. PubMed ID: 1698863 [TBL] [Abstract][Full Text] [Related]
3. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Clayton LK; Sieh M; Pious DA; Reinherz EL Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930 [TBL] [Abstract][Full Text] [Related]
4. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex. Lustgarten J; Waks T; Eshhar Z Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555 [TBL] [Abstract][Full Text] [Related]
5. CD4 binding to major histocompatibility complex class II antigens induces LFA-1-dependent and -independent homotypic adhesion of B lymphocytes. Kansas GS; Cambier JC; Tedder TF Eur J Immunol; 1992 Jan; 22(1):147-52. PubMed ID: 1730248 [TBL] [Abstract][Full Text] [Related]
6. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827 [TBL] [Abstract][Full Text] [Related]
7. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120. Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755 [TBL] [Abstract][Full Text] [Related]
8. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463 [TBL] [Abstract][Full Text] [Related]
9. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582 [TBL] [Abstract][Full Text] [Related]
11. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity. Jabado N; Le Deist F; Fisher A; Hivroz C Eur J Immunol; 1994 Nov; 24(11):2646-52. PubMed ID: 7957556 [TBL] [Abstract][Full Text] [Related]
12. Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help. Chirmule N; Wang XP; Hu R; Oyaizu N; Roifman C; Pahwa R; Kalyanaraman VS; Pahwa S Cell Immunol; 1994 Apr; 155(1):169-82. PubMed ID: 8168144 [TBL] [Abstract][Full Text] [Related]
13. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules. Wacholtz MC; Patel SS; Lipsky PE J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819 [TBL] [Abstract][Full Text] [Related]
14. HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. Houlgatte R; Scarmato P; el Marhomy S; Martin M; Ostankovitch M; Lafosse S; Vervisch A; Auffray C; Platier-Tonneau D J Immunol; 1994 May; 152(9):4475-88. PubMed ID: 7512597 [TBL] [Abstract][Full Text] [Related]
15. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition. Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152 [TBL] [Abstract][Full Text] [Related]
16. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation. Clement LT; Tedder TF; Gartland GL J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149 [TBL] [Abstract][Full Text] [Related]
17. CD4+ class I-restricted T cells specific for HIV gp160 315-329. Moore RL; Fox BS Cell Immunol; 1994 Mar; 154(1):43-53. PubMed ID: 7907008 [TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749 [TBL] [Abstract][Full Text] [Related]
19. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo. Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160 [TBL] [Abstract][Full Text] [Related]
20. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells. Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]